Ado-Trastuzumab Emtansine

Preferred Label : Ado-Trastuzumab Emtansine;

MeSH definition : Immunotoxin that consists of humanized monoclonal anti-HER2 antibody TRASTUZUMAB covalently linked to anti-microtubule agent MAYTANSINOID DM1 for treatment of metastatic breast cancer in patients who previously received trastuzumab and a TAXANES, separately or in combination.;

MeSH synonym : Ado Trastuzumab Emtansine; Trastuzumab Emtansine;

MeSH hyponym : huN901 DM1; huN901DM1; Trastuzumab DM1 Conjugate; Trastuzumab-DM1; Trastuzumab DM1;

Wikipedia link : https://en.wikipedia.org/wiki/Ado-trastuzumab emtansine;

UNII : SE2KH7T06F;

Details

Origin ID

D000080044;

UMLS CUI

C2935436;

ATC code(s)
- trastuzumab emtansine [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- analysis [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- drug effects [MeSH Qualifier]
- economics [MeSH Qualifier]
- genetics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- ultrastructure [MeSH Qualifier]
- urine [MeSH Qualifier]
Automatic exact mappings (from CISMeF team)
- Lorvotuzumab Mertansine [NCIt concept]
Currated CISMeF NLP mapping
- Trastuzumab Emtansine [NCIt concept]
- Trastuzumab Emtansine [Anticorps monoclonal]
- Trastuzumab emtansine [ICD-11 Extension code]
- Trastuzumab emtansine [SMS substance]
- Trastuzumab emtansine (substance) [SNOMED CT concept]
- trastuzumab emtansine [International Nonproprietary Name]
- trastuzumab emtansine [ATC Code]
Pharmacological action(s)
- Antineoplastic Agents, Immunological [MeSH Descriptor]
- immunologic factors [MeSH Descriptor]
- immunotoxins [MeSH Descriptor]
- tubulin modulators [MeSH Descriptor]
Record concept(s)
- ado-trastuzumab emtansine [MeSH concept]
- huN901-DM1 [MeSH concept]
- kadcyla [MeSH concept]
- trastuzumab-DM1 conjugate [MeSH concept]
See also inter- (CISMeF)
- Ado-trastuzumab Emtansine Regimen [NCIt concept]
Semantic type(s)
- Amino Acid, Peptide, or Protein [UMLS semantic type]
- Immunologic Factor [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Product containing trastuzumab emtansine (medicinal product) [SNOMED CT concept]
- Trastuzumab Emtansine [NCIt concept]
- Trastuzumab emtansine (substance) [SNOMED CT concept]
- trastuzumab emtansine [ATC Code]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients